ArticleFrontiers in public health2026
Capacity, motivation, and opportunity model-derived taxonomy of pharmacist-led interventions applicable to people self-managing cancer medication.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: With health systems facing increasing challenges, it is important to define new care models that may release some of the burden on the workforce, whilst maintaining quality and improving patient convenience. The objective of this study was to create a taxonomy of pharmacist-led interventions aimed at supporting improved health outcomes of people self-managing cancer medication. Methods: The list was developed following a literature search conducted in Cochrane Library and MEDLINE (PubMed) databases. The Capacity, Motivation and Opportunity (CMO) model developed for people living with HIV was used as theoretical framework to organise the pharmacist-led interventions emerging from literature. A panel of experts (hospital pharmacists with experience in oncology) selected through national hospital pharmacy societies was invited to participate in a consensusseeking Delphi survey, focusing on the most important and feasible interventions. Results: A total of 28 experts answered and rated 39 interventions. Whilst 35 of the proposed pharmacist-led interventions were considered important (median score above 8, on a scale of 1 to 9, without disagreement among experts), only eight were considered feasible for implementation in practice. The most frequently mentioned reasons for others not to be feasible were understaffing and excessive workload. Nevertheless, there were interventions considered vital for patients' care and hence kept in the final taxonomy. Discussion: Future hospital-based studies should incorporate this taxonomy based on the CMO model to measure pharmacists' interventions in real clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.